Search

everythinglearnresearchcommunity

for

Search:↓

Capecitabine is as effective as intravenous treatments with fewer side effects, but requires careful management of Hand-foot syndrome and patient education.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Chemotherapy can cause brain inflammation and damage, and understanding this process could help manage side effects.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Calcipotriol plus betamethasone with microneedling works better than tacrolimus for treating vitiligo.

Asiasari Radix et Rhizoma is safe and has potential for new drug development due to its therapeutic properties.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

Bimatoprost is safe and improves eyelash growth in healthy kids but not in those with eyelash loss from chemotherapy or alopecia.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

A woman developed severe bladder inflammation after cancer treatment with Cytoxan.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Cacumen Platycladi oil promotes hair growth better than minoxidil.

New drugs for rheumatoid arthritis show improvement but have side effects and are not a cure.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.